SAN ANTONIO--(BUSINESS WIRE)--bioAffinity Technologies, (NASDAQ: BIAF, BIAFW), a biotechnology company that develops noninvasive, early-stage diagnostics to detect cancer and diseases of the lung, ...
BioAffinity Technologies said on Wednesday that it will run a study of its CyPath Lung test for early lung cancer detection in collaboration with Brooke Army Medical Center (BAMC). CyPath Lung ...
SAN ANTONIO--(BUSINESS WIRE)-- bioAffinity Technologies’ (Nasdaq: BIAF; BIAFW) Vice President of Diagnostics, Jennifer Rebeles, Ph.D., was part of a panel of worldwide experts that published the ...
SAN ANTONIO--(BUSINESS WIRE)-- bioAffinity Technologies, Inc., (NASDAQ: BIAF; BIAFW) will present results of its research into the use of flow cytometry for analyzing the lung environment to detect ...
To investigate their recruitment, Gata6-iCreER mice were crossed with Cd45-Dre and R26-tdT mice, enabling specific lineage tracing of cavity macrophages. Flow cytometry and immunofluorescence ...
Macrophages have been implicated in both the resolution and progression of influenza, but the drivers of these outcomes are poorly understood. We probed mouse lung transcriptomic datasets using tissue ...
At the height of the SARS-CoV-2 pandemic, researchers in Thomas Marichal’s immunophysiology laboratory at the University of Liège were studying samples collected from the lungs of patients who had ...
Since the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) first emerged at the end of 2019, it has infected over 525 million people worldwide and caused almost 6.3 million deaths. While ...
Preclinical studies indicate that cavity-resident macrophages in the peritoneal and pleural spaces contribute to immunosuppression and cancer progression. While these macrophages typically accumulate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results